AZ To Enter Japanese Diabetes Market In July
This article was originally published in PharmAsia News
AstraZeneca Japan will move into a new sales and marketing system divided by disease area from July onwards, the company announced on June 12.
You may also be interested in...
Political tensions between Switzerland and the EU have led to concerns about the future status of the only Swiss medtech notified body, SQS. Here’s what SQS board member Daniel Taddeo said about the situation.
Agency officials determining needs using existing budgets before requesting more funds and will engage with tech investors for design advice.